GHK-Cu in Australia: A Plain-English Research Guide
GHK-Cu — also written as GHK Cu, or copper-glycyl-L-histidyl-L-lysine — is one of the most extensively studied research compounds in the published literature. It’s a copper-binding research compound that naturally occurs in human plasma, and researchers have been investigating its biological activity for more than fifty years. This guide is a plain-English overview for Australian researchers and anyone curious about what the science actually says.
What is GHK-Cu?
Chemically, GHK is a sequence of just three amino acids: glycine, histidine and lysine. On its own, the research compound has an unusually high affinity for copper (II) ions — when bound, the resulting complex is referred to as GHK-Cu or the “copper research compound”.
It was first isolated from human plasma in 1973 by Loren Pickart, who observed that plasma fractions from younger donors had a particular regenerative activity in liver tissue cultures. The active component turned out to be GHK, paired with copper.
Why researchers find it interesting
The bulk of GHK-Cu research falls into a few broad areas. None of this is medical advice — these are simply the lines of inquiry the published literature has explored:
- Skin and dermal research. A large body of in vitro and ex vivo work has examined GHK-Cu in the context of collagen synthesis, fibroblast signalling and dermal matrix remodelling.
- Hair follicle research. Several studies have investigated GHK-Cu in models of hair follicle activity and dermal papilla cell behaviour.
- Wound and tissue research. GHK-Cu has been studied in cell-culture and animal models of tissue repair, with attention to inflammatory signalling and matrix turnover.
- Gene expression. A 2010 paper by Pickart and colleagues reported that GHK influences the expression of a wide range of human genes in cultured fibroblasts — a finding that drove much of the subsequent interest in the research compound.
How GHK binds copper
The histidine and lysine residues in the GHK research compound form a high-affinity coordination site for copper (II). In vivo, GHK appears to act as a copper shuttle — picking up copper ions and delivering them into cells. Free copper is tightly regulated and potentially cytotoxic; bound copper, in contrast, is bioavailable in a controlled way. This is part of what makes the GHK-Cu complex distinct from supplementary copper alone.
What the research does NOT say
It’s worth being clear about what GHK-Cu research is and isn’t. Most studies have been conducted in vitro, in animal models, or in small cosmetic-focused human trials. Large, randomised clinical trials of GHK-Cu in any clinical indication are limited. Strong therapeutic claims go well beyond the data — and a careful researcher should treat them with appropriate scepticism.
Sourcing GHK-Cu in Australia
For Australian researchers, the practical sourcing concerns are:
- Purity. Look for suppliers who can demonstrate purity, ideally with third-party HPLC and mass spectrometry data. Research compound synthesis quality varies, and impurities can confound research.
- Provenance. An Australian-based supplier means shorter cold-chain exposure during transit and fewer customs delays.
- Storage. GHK-Cu is supplied lyophilised. Once reconstituted, it should be kept refrigerated and used within the window stated by your supplier. See our research compound storage guide for the practical details.
Where to learn more
A good starting point in the literature is the 2018 review by Pickart and Margolina, “Regenerative and Protective Actions of the GHK-Cu Research Compound in the Light of the New Gene Data”. From there, follow citations into the dermal, hair and gene expression studies that interest you most.
If you’re ready to source research-grade material, you can buy GHK-Cu 100mg from AUSPEPS — shipped free express, Australia-wide, for research and educational use only.